Overview

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Status:
Withdrawn
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of apomorphine, given by two different methods, to determine how best to manage dyskinesias.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Apomorphine